AngioDynamics Company Profile (NASDAQ:ANGO)

About AngioDynamics (NASDAQ:ANGO)

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ANGO
  • CUSIP: 03475V10
  • Web:
  • Market Cap: $646.94 million
  • Outstanding Shares: 36,715,000
Average Prices:
  • 50 Day Moving Avg: $17.45
  • 200 Day Moving Avg: $16.38
  • 52 Week Range: $14.80 - $18.85
  • Trailing P/E Ratio: 177.98
  • Foreward P/E Ratio: 23.81
  • P/E Growth: 1.92
Sales & Book Value:
  • Annual Revenue: $346.96 million
  • Price / Sales: 1.86
  • Book Value: $13.99 per share
  • Price / Book: 1.26
  • EBITDA: $47.67 million
  • Net Margins: 1.64%
  • Return on Equity: 4.83%
  • Return on Assets: 3.57%
  • Debt-to-Equity Ratio: 0.17%
  • Current Ratio: 2.34%
  • Quick Ratio: 1.48%
  • Average Volume: 240,734 shs.
  • Beta: 1.12
  • Short Ratio: 7.79

Frequently Asked Questions for AngioDynamics (NASDAQ:ANGO)

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) announced its earnings results on Thursday, September, 28th. The company reported $0.12 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.16 by $0.04. The business earned $85.40 million during the quarter, compared to analyst estimates of $86.12 million. AngioDynamics had a net margin of 1.64% and a return on equity of 4.83%. The business's quarterly revenue was down 3.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.17 earnings per share. View AngioDynamics' Earnings History.

When will AngioDynamics make its next earnings announcement?

AngioDynamics is scheduled to release their next quarterly earnings announcement on Thursday, January, 4th 2018. View Earnings Estimates for AngioDynamics.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics updated its FY18 earnings guidance on Thursday, September, 28th. The company provided earnings per share (EPS) guidance of $0.64-0.68 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.67. The company issued revenue guidance of $352-359 million, compared to the consensus revenue estimate of $355.58 million.

Where is AngioDynamics' stock going? Where will AngioDynamics' stock price be in 2017?

5 brokerages have issued twelve-month price objectives for AngioDynamics' shares. Their predictions range from $16.00 to $21.00. On average, they expect AngioDynamics' share price to reach $18.50 in the next twelve months. View Analyst Ratings for AngioDynamics.

What are analysts saying about AngioDynamics stock?

Here are some recent quotes from research analysts about AngioDynamics stock:

  • 1. According to Zacks Investment Research, "AngioDynamics reported a dismal first quarter of fiscal 2018 wherein adjusted earnings and revenues missed the Zacks Consensus Estimate. The company reaffirmed its guidance for fiscal 2018. AngioDynamicis rides on the market’s solid response to Solero, especially within the Microwave Ablation space. Growth in the core Angiographic Catheter business is also likely to fortify the company’s footprint in the global space. On the flipside, AngioDynamics recalled the Acculis Microwave Tissue Ablation System under the Oncology and Surgery segment last quarter. The company also had a high outstanding debt level at the end of the first quarter. Higher debts impose certain operating and financial restrictions which might limit the execution of the company’s core business strategies. AngioDynamics traded below the broader industry in the past year." (10/3/2017)
  • 2. Cantor Fitzgerald analysts commented, "F3Q17 Result Summary. F3Q17 total revenues of $85.6M (down 2.0% y/y), was $3.2M below our estimate of $88.8M and $2.7M below FactSet consensus of $88.3M." (3/30/2017)

Who are some of AngioDynamics' key competitors?

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the folowing people:

  • Howard W. Donnelly, Independent Chairman of the Board
  • James C. Clemmer, President, Chief Executive Officer, Director
  • Michael Greiner, Chief Financial Officer, Executive Vice President
  • Gary Barrett, Senior Vice President,Quality and Regulatory Affairs
  • Ben Davis, Senior Vice President, Business Development
  • Barbara Kucharczyk, Senior Vice President-Global Operations
  • Stephen A. Trowbridge, Senior Vice President, General Counsel
  • Eileen O'Shea Auen, Director
  • Jan Stern Reed, Director
  • David F. Burgstahler, Independent Director

How do I buy AngioDynamics stock?

Shares of AngioDynamics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AngioDynamics' stock price today?

One share of AngioDynamics stock can currently be purchased for approximately $17.62.

MarketBeat Community Rating for AngioDynamics (NASDAQ ANGO)
Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  199 (Vote Underperform)
Total Votes:  322
MarketBeat's community ratings are surveys of what our community members think about AngioDynamics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for AngioDynamics (NASDAQ:ANGO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $18.50 (4.99% upside)
Consensus Price Target History for AngioDynamics (NASDAQ:ANGO)
Price Target History for AngioDynamics (NASDAQ:ANGO)
Analysts' Ratings History for AngioDynamics (NASDAQ:ANGO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/8/2017Canaccord GenuityReiterated RatingHold$17.00N/AView Rating Details
9/29/2017KeyCorpReiterated RatingHoldHighView Rating Details
7/19/2017Barclays PLCLower Price TargetEqual Weight$17.00 -> $16.00LowView Rating Details
7/4/2017Cantor FitzgeraldBoost Price TargetOverweight$20.00 -> $21.00LowView Rating Details
4/1/2017Craig HallumSet Price TargetBuy$20.00LowView Rating Details
4/8/2016Piper Jaffray CompaniesInitiated CoverageNeutral$12.00N/AView Rating Details
11/10/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for AngioDynamics (NASDAQ:ANGO)
Earnings by Quarter for AngioDynamics (NASDAQ:ANGO)
Earnings History by Quarter for AngioDynamics (NASDAQ ANGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/4/2018$0.16N/AView Earnings Details
9/28/2017Q1 2018$0.16$0.12$86.12 million$85.40 millionViewN/AView Earnings Details
7/18/2017Q4 2017$0.16$0.19$90.72 million$86.90 millionViewN/AView Earnings Details
3/30/2017Q3 2017$0.15$0.19$88.29 million$85.60 millionViewN/AView Earnings Details
1/6/2017Q217$0.16$0.19$91.09 million$89.00 millionViewListenView Earnings Details
10/5/2016Q117$0.13$0.17$86.09 million$88.10 millionViewN/AView Earnings Details
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details
4/7/2016Q3$0.14$0.15$85.43 million$87.40 millionViewListenView Earnings Details
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details
10/8/2015Q116$0.11$0.11$84.70 million$83.70 millionViewN/AView Earnings Details
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details
4/9/2015Q315$0.15$0.12$88.69 million$86.60 millionViewN/AView Earnings Details
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details
10/9/2014Q115$0.11$0.16$85.35 million$87.30 millionViewListenView Earnings Details
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details
7/12/2012$0.08$0.09ViewN/AView Earnings Details
4/4/2012$0.07$0.09ViewN/AView Earnings Details
1/5/2012$0.12$0.13ViewN/AView Earnings Details
10/6/2011$0.09$0.08ViewN/AView Earnings Details
7/14/2011$0.10$0.11ViewN/AView Earnings Details
4/5/2011$0.12$0.15ViewN/AView Earnings Details
1/4/2011$0.12$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for AngioDynamics (NASDAQ:ANGO)
2017 EPS Consensus Estimate: $0.61
2018 EPS Consensus Estimate: $0.71
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.13$0.13$0.13
Q2 20171$0.17$0.17$0.17
Q3 20172$0.15$0.16$0.16
Q4 20172$0.14$0.16$0.15
Q1 20182$0.14$0.18$0.16
Q2 20182$0.15$0.16$0.16
Q3 20182$0.18$0.23$0.21
Q4 20182$0.15$0.23$0.19
(Data provided by Zacks Investment Research)


Dividend History for AngioDynamics (NASDAQ:ANGO)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for AngioDynamics (NASDAQ:ANGO)
Insider Ownership Percentage: 1.80%
Institutional Ownership Percentage: 95.42%
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)
Insider Trades by Quarter for AngioDynamics (NASDAQ:ANGO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/24/2017Jan Stern ReedDirectorBuy316$16.00$5,056.00View SEC Filing  
7/21/2017James C ClemmerCEOBuy5,000$15.79$78,950.00View SEC Filing  
7/20/2017James C ClemmerCEOBuy20,000$15.64$312,800.00View SEC Filing  
4/12/2017Avista Capital Partners Gp, LlMajor ShareholderSell2,350,000$16.00$37,600,000.00View SEC Filing  
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00View SEC Filing  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.00View SEC Filing  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for AngioDynamics (NASDAQ:ANGO)
Latest Headlines for AngioDynamics (NASDAQ:ANGO)
Loading headlines, please wait.



AngioDynamics (ANGO) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.